Evaluation of MRI characterisation of histopathologically matched lymph nodes and other mesorectal nodal structures in rectal cancer
- 1Department of Diagnostics and Intervention, Diagnostic Radiology, Umeå University, Umeå, Sweden. miriam.rutegard@umu.se.
- 2Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
- 3Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna, Sweden.
- 4Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
- 5Department of Diagnostics and Intervention, Radiation Physics, Umeå University, Umeå, Sweden.
- 6Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden.
- 7Department of Diagnostics and Intervention, Diagnostic Radiology, Umeå University, Umeå, Sweden.
- 0Department of Diagnostics and Intervention, Diagnostic Radiology, Umeå University, Umeå, Sweden. miriam.rutegard@umu.se.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Current MRI criteria for rectal cancer nodal staging, including the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) criteria, show potential but require caution due to limited accuracy in predicting malignancy. Further validation is needed for precise nodal staging.
Area Of Science
- Radiology
- Oncology
- Gastroenterology
Background
- Accurate lymph node staging in rectal cancer is critical for effective treatment planning.
- Current magnetic resonance imaging (MRI) criteria for assessing mesorectal nodal structures have limitations.
Purpose Of The Study
- To evaluate the diagnostic performance of current MRI-based criteria for malignancy in mesorectal lymph nodes in rectal cancer.
- To assess the utility of the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus criteria for nodal staging.
Main Methods
- Anatomical comparison of mesorectal nodal structures on baseline MRI with histopathological findings (lymph nodes, tumor deposits, extramural venous invasion).
- Inclusion of matched nodal structures from primary surgery patients and all malignant nodes from neoadjuvant treatment patients.
- Logistic regression analysis of morphological criteria (irregular margin, round shape, heterogeneous signal, size) and ESGAR criteria against histopathological nodal status.
Main Results
- Short-axis diameter ≥ 5 mm (OR 21.43) and heterogeneous signal (OR 9.02) were significantly associated with malignancy in univariable analysis.
- Nodal size remained the strongest predictor in multivariable analysis (OR 12.32).
- The ESGAR criteria showed an odds ratio of 8.23 for malignant outcome, with a sensitivity of 54% and specificity of 85%.
Conclusions
- Morphological and size criteria play a role in predicting lymph node metastases in rectal cancer.
- Current MRI criteria, including ESGAR consensus criteria, may not be sufficiently accurate for definitive nodal staging.
- These criteria should be used cautiously in clinical practice, highlighting the need for improved nodal staging methods.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:25
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
01:24
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

